All Champix®
(varenicline) products are unavailable until further notice with very limited
residual stock may be available in pharmacies.
- Patients
currently prescribed this treatment will require review and switching to
nicotine replacement therapy (NRT) unless contraindicated.
- No new patients
should be initiated on Champix® (varenicline) products.
- Prescribers
initiating smoking cessation treatment for new patients should consider
prescribing NRT or bupropion 150mg prolonged release tablets unless contraindicated.
- Helping a
patient to stop smoking should not be delayed if they are motivated to stop as
other effective options are available.
This alert
contains further information and action for providers.
Please note
that no response is required via the CAS website to this alert.